Top 7 sources of the fuel that feed cancer – the warped cell generator

(Natural News) For 75 years, the American sick-care system has convinced nearly all Americans that chemotherapy is the only way to even attempt to beat cancer. It’s all been one big horrible lie. First off, we all have cancer cells in our body right now. The only way doctors ever even notice cancer cells is...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news

Related Links:

ConclusionDirect-to-implant IBR after skin-sparing mastectomy is a viable option for breast cancer patients undergoing neoadjuvant chemotherapy.ResumenIntroducciónLa reconstrucción inmediata (RMI) tras mastectomía en pacientes que han recibido quimioterapia neoadyuvante (QTNA) sigue siendo controvertida. El objetivo de este estudio es analizar y comparar resultados oncológicos y las tasas de complicaciones y reintervención en pacientes sometidas a QTNA y un grupo control.MétodosAnálisis observacional retrospectivo de casos-controles. Pacientes con cáncer de mama inter...
Source: Cirugia Espanola - Category: Surgery Source Type: research
In this study, we showed that non-cytotoxic concentrations of R. coriaria reduces uterus cervix cell migration capacity. We have also found that R. coriaria has a growth inhibitory effect on cervical cancer cells in a time- and a concentration-dependent manner. We have carried out a phytochemical compound analysis of R. coriaria extract using liquid chromatography – mass spectrometry method in order to identify bioactive compounds in R. coriaria extract that could potentially induce its anti-cancer effects. Our results are promising to involve R. coriaria as a therapeutic drug candidate for uterus cervix cancer.
Source: Revista Brasileira de Farmacognosia - Category: Drugs & Pharmacology Source Type: research
Condition:   Triple Negative Breast Neoplasms Interventions:   Biological: Pembrolizumab;   Drug: Olaparib;   Drug: Carboplatin;   Drug: Gemcitabine Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Abstract Type I interferons (IFNs) facilitate cancer immunosurveillance, antitumor immunity and antitumor efficacy of conventional cell death-inducing therapies (chemotherapy/radiotherapy) as well as immunotherapy. Moreover, it is clear that dendritic cells (DCs) play a significant role in aiding type I IFN-driven immunity. Owing to these antitumor properties several immunotherapies involving, or inducing, type I IFNs have received considerable clinical attention, e.g., recombinant IFNα2 or agonists targeting pattern recognition receptor (PRR) pathways like Toll-like receptors (TLRs), cGAS-STING or RIG-I/MDA...
Source: International Review of Cell and Molecular Biology - Category: Cytology Authors: Tags: Int Rev Cell Mol Biol Source Type: research
Palbociclib, also known as Ibrance, targets weaknesses in cancer to stop cells dividing and spreading - delaying the need for chemotherapy adding years to the lives of women with the disease.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
(University of Texas M. D. Anderson Cancer Center) A Phase II study pairing azacitidine with enasidenib boosts complete remission in patients with AML with IDH2 mutations.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
This study will aim to evaluate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in colorectal cancer patients.Methods/designWe will carry out an 8-week double-blind randomized, placebo-controlled clinical trial to evaluate the effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with stage ӀӀ or ӀӀӀ colorectal cancer undergoing chemotherapy.DiscussionBecause of the important effects of vitamin D and omega-3 fatty acids on molecular pathways...
Source: Trials - Category: Research Source Type: clinical trials
DiscussionThe ELEMENT trial is designed to assess whether EUS-guided choledochoduodenostomy using a dedicated LAMS is superior to conventional ERCP as a first-line endoscopic drainage approach in malignant distal biliary obstruction, which is an important and timely question that has not been addressed using an RCT study design.Trial registrationRegistry name: ClinicalTrials.gov. Registration number:NCT03870386. Date of registration: 03/12/2019.
Source: Trials - Category: Research Source Type: clinical trials
ConclusionThis phase II trial using pemetrexed/erlotinib in metastatic CRC with high EGFR expression met the primary endpoint of tumor response.Trial RegistrationThis study was registered at ClinicalTrials.gov (number NCT03086538).
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
alho Giovanna B. Longato Glioblastoma (GBM) is the most frequent and highest–grade brain tumor in adults. The prognosis is still poor despite the use of combined therapy involving maximal surgical resection, radiotherapy, and chemotherapy. The development of more efficient drugs without noticeable side effects is urgent. Coronarin D is a diterpene obtained from the rhizome extract of Hedychium coronarium, classified as a labdane with several biological activities, principally anticancer potential. The aim of the present study was to determine the anti–cancer properties of Coronarin D in the gliobl...
Source: Molecules - Category: Chemistry Authors: Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Health